Mechanisms of colorectal liver metastasis development
Open Access
- 27 November 2022
- journal article
- review article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 79 (12) , 1-17
Abstract
Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide, largely due to the development of colorectal liver metastases (CRLM). For the establishment of CRLM, CRC cells must remodel their tumor-microenvironment (TME), avoid the immune system, invade the underlying stroma, survive the hostile environment of the circulation, extravasate into the liver, reprogram the hepatic microenvironment into a permissive pre-metastatic niche, and finally, awake from a dormant state to grow out into clinically detectable CRLM. These steps form part of the invasion-metastasis cascade that relies on reciprocal interactions between the tumor and its ever-changing microenvironment. Such interplay provides a strong rational for therapeutically targeting the TME. In fact, several TME constituents, such as VEGF, TGF-β coreceptor endoglin, and CXCR4, are already targeted in clinical trials. It is, however, of utmost importance to fully understand the complex interactions in the invasion-metastasis cascade to identify novel potential therapeutic targets and prevent the establishment of CRLM, which may ultimately greatly improve patient outcome.Keywords
This publication has 166 references indexed in Scilit:
- Dependency of Colorectal Cancer on a TGF-β-Driven Program in Stromal Cells for Metastasis InitiationCancer Cell, 2012
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerNew England Journal of Medicine, 2012
- Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in boneJournal of Experimental Medicine, 2011
- Chemokine nitration prevents intratumoral infiltration of antigen-specific T cellsJournal of Experimental Medicine, 2011
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal CancerNew England Journal of Medicine, 2009
- ATF6α-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivoProceedings of the National Academy of Sciences, 2008
- Models, mechanisms and clinical evidence for cancer dormancyNature Reviews Cancer, 2007
- Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed?The Lancet Oncology, 2007
- Dissemination and growth of cancer cells in metastatic sitesNature Reviews Cancer, 2002
- Multistep Nature of Metastatic InefficiencyThe American Journal of Pathology, 1998